HopeStage
Back to all studies
CompletedNCT04128683

Dopamine and Learning From Outcomes in Anorexia

About this title

Dopamine Receptor Contributions to Prediction Error and Reversal Learning in Anorexia Nervosa

Read the official source — NCT04128683
Medication studyAges 18–29United StatesEating disorders
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 29 years.

Listed locations
San DiegoSee all locations and recruitment
Study phase
Early phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: October 20, 2020
Recruitment status
Completed
Enrollment listed in the registry
31
Sponsor
University of California, San Diego
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Early Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
Locations
United States
Age range
From 18 Years to 29 Years
Official registry ID
NCT04128683
Official title
Show the full official title

Toward Understanding Dopamine Receptor Contributions to Prediction Error and Reversal Learning in Anorexia Nervosa

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

San Diego

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of California, San Diego, a university.

Did this study involve medication?

Yes. The study involved medication, including amisulpride, bromocriptine and Placebo.

Who was this study for?

Listed age limits: 18 years to 29 years.

Want to explore more studies?

Explore studies